Catheterization Lab Equipment in New York

SoftLink International is a healthcare IT company headquartered in India, founded in 1997, specializing in software solutions for hospital automation, clinical informatics, patient workflow management, and analytics. The company serves over 450 healthcare institutions across 15 countries, with significant deployments in the USA, Middle East, India, and Far East. Core product offerings include PANACEA (Hospital Information Management System/HIMS), a comprehensive EHR/EMR platform supporting full hospital digitization and paperless operations; Cardiology Solutions (CVIS—Cardiovascular Information System) providing multimodality viewing, cath lab inventory management, and research tools; Radiology Solutions delivering end-to-end PACS (Picture Archiving and Communication Systems) from single clinics to enterprise deployments; and TeleHealth Solutions functioning as standalone or integrated remote consultation platforms. The company maintains compliance certifications including FDA, HIPAA, ISO 9001, ISO 27001, DICOM, HL7, ICD-10, and IHE standards. SoftLink provides custom engineering, system integration, and data migration services. Known strengths include deep EHR/EMR integration experience (compatibility with EPIC, Cerner, and proprietary systems), support for non-DICOM modalities, and agile product innovation. The firm operates on a turnkey model, reducing dependency on third-party vendors. Clientele includes major hospital chains (Apollo, Fortis, Max Healthcare, Mount Sinai), government medical institutions (JIPMER), and specialty centers across multiple disciplines.

Radformation is a healthcare technology company specializing in AI-driven automation software for radiation oncology workflows. Founded in 2016 and based in New York, the company develops intelligent tools that enhance efficiency, reduce errors, and improve cancer treatment planning across oncology clinics. Radformation's integrated platform supports the complete treatment lifecycle—from automated contouring and planning to quality assurance, treatment monitoring, and billing automation. Key offerings include AutoContour (480+ deep-learning anatomical structures), EZFluence (3D automated planning), ClearCheck (plan evaluation), ClearCalc (independent dose calculation), RadMonteCarlo (Monte Carlo calculations), ChartCheck (real-time treatment monitoring), ChartCheck Adaptive (adaptive dose tracking), QuickCode (billing QA), and RadMachine (machine QA). The platform seamlessly integrates with Eclipse™ TPS and supports photon, electron, proton, and brachytherapy modalities. With over 1,400 clinic installations and multiple regulatory clearances, Radformation enables cancer treatment centers to standardize workflows, increase patient throughput, and deliver safer, higher-quality radiation treatments.

AngioDynamics, Inc. is a medical device manufacturer specializing in innovative interventional oncology and peripheral vascular disease treatment solutions. The company develops and markets advanced percutaneous medical devices and systems designed to improve patient outcomes in two primary clinical areas: cardiovascular disease management and cancer treatment. Key product platforms include the Auryon System, a peripheral atherectomy device for treating arterial lesions and peripheral artery disease; the AlphaVac System, designed for efficient clot removal from large vessels; and the NanoKnife System, a precision ablation platform for oncologic and cardiac applications. These systems leverage advanced technologies including irreversible electroporation, mechanical thrombectomy, and minimally invasive atherectomy. The company is committed to clinical evidence generation, with active research and clinical studies demonstrating safety and efficacy. AngioDynamics serves interventional radiologists, interventional cardiologists, and surgical oncologists across hospital and outpatient settings. The organization emphasizes partnerships in care and maintaining a talented workforce dedicated to advancing medical innovation. Based in Glens Falls, New York, AngioDynamics operates as a publicly traded medical device innovator focused on expanding treatment options and developing care pathways for cardiovascular and oncologic patient populations.

Baylis Medical Technologies is a medical device manufacturer specializing in endovascular intervention solutions for vascular and interventional procedures. The company designs and commercializes state-of-the-art access and crossing technologies that enable healthcare professionals to navigate complex vascular anatomy and treat previously challenging or unreachable lesions. Primary product lines include radiofrequency (RF) guidewires and steerable sheaths for peripheral vascular interventions, occlusion crossing, and stent-related procedures. Key products include PowerWire® Pro RF Guidewire (for crossing totally occluded peripheral vessels ≥3 mm, including stented vessels), PowerWire® Pulse RF Guidewire (with biliary intervention applications), and Passport® Steerable Sheath (for vascular navigation and precision access). The company operates manufacturing facilities in Mississauga, Ontario, Canada, with US operations headquartered in Fort Worth, Texas. Baylis supports clinical adoption through comprehensive online education, physician training programs, and clinical support services. Products are distributed globally to interventional cardiologists, vascular surgeons, and interventional radiologists. The company emphasizes evidence-based clinical outcomes, publishing and disseminating independent clinical studies through its Office of Scientific Affairs. Regional regulatory compliance and approval status vary by jurisdiction.

Anest Iwata Sparmax is a world-class compressor and vacuum pump manufacturer serving medical, life science, and industrial markets. The company specializes in oil-less, piston, and diaphragm pump and compressor technologies. Core product lines include vacuum pumps for laboratory and medical applications (air sampling, liquid filtration, surgical/catheter aspiration, veterinary suction) and compressors for oxygen concentrators, nebulizers, disinfectant systems, and medical aspirators. The company operates through branded divisions: Cliq (medical devices) and Sparmax (consumer/airbrush). Manufacturing capabilities encompass design engineering, circuit and housing design, CNC machining of compressor components and pneumatic accessories, and field-ready system integration. All production occurs in TUV-certified Taiwan facilities compliant with ISO 9001 (quality), ISO 13485 (medical devices), and ISO 14001 (environmental management). The company provides OEM/ODM custom solutions, including modification of existing platforms and ground-up design for specific flow, pressure, and application requirements. Private labeling and packaging customization available. Notable medical applications include veterinary nebulizers (Equi-Resp), animal health products (MAI Animal Health Auri-Kleen), and neurovascular/cardiovascular suction systems. Parent company Anest Iwata brings global reach and air energy technology expertise.

LSI Solutions, Inc. is a medical device manufacturer specializing in innovative surgical instruments and suturing solutions for minimally invasive and open surgical procedures. The company develops proprietary devices for cardiac, general, gynecological, and urological surgery, with particular expertise in mitral valve repair and aortic valve replacement procedures. Their product portfolio includes the RAM (Rapid Annular Materialization) device—an automated titanium fastener system for annular suturing—and related instruments designed to enhance surgical precision, reduce operative time, and improve patient outcomes. LSI Solutions markets and distributes through a global network spanning North America, Europe, Asia-Pacific, the Middle East, and Latin America. The company maintains its global headquarters in Victor, New York, and demonstrates active engagement in surgical innovation through conference participation (AATS 2026, Re-Evolution Summit) and peer-reviewed research publications. Their device portfolio is positioned for cardiac surgeons performing endoscopic and minimally invasive procedures, with clinical evidence supporting safety, efficacy, and reduced complication rates (including lower infective endocarditis risk compared to hand-knot suturing). The company offers 24-hour technical support and maintains regulatory compliance appropriate for US medical device distribution.

Spectrum Vascular is a medical device manufacturer founded in 2023, specializing in vascular access and medication management solutions with a focus on reducing catheter-related complications. The company develops a range of central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midline catheters, and arterial lines incorporating proprietary antimicrobial and thromboresistant technologies. SV Spectrum™ Technology features antimicrobial catheters designed to prevent central line-associated bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI), validated by over 30 peer-reviewed studies. SV BioFlo Technology incorporates Endexo® surface-modifying macromolecules to minimize thrombus accumulation and catheter occlusions throughout the catheter's lifespan. Additional offerings include intraosseous (IO) needles, ECG-guided catheter placement systems, and accessory products. Spectrum Vascular's mission addresses the significant clinical and economic burden of vascular access infections and complications, with typical CRBSI treatment costs exceeding $45,000 per case.

The Jacobs Institute is a not-for-profit vascular medical technology innovation center located in Buffalo, New York, uniquely positioned as the only independently managed medical innovation facility operating within a single building. Strategic proximity to Kaleida Health's Gates Vascular Institute and the University at Buffalo's Clinical and Translational Research Center enables seamless collaboration for medical device development. The institute's core mission centers on accelerating next-generation vascular medicine technologies through partnerships between physicians, engineers, entrepreneurs, and industry stakeholders. Key service offerings include the i2R (Idea to Reality) Center, which guides medical device development from ideation through FDA submission; regulatory and quality compliance services; clinical training programs; and a 3D Printing Center of Excellence in Health Care specializing in customizable 3D-printed vascular flow models for anatomical visualization and product testing. The institute also operates education and community programs designed to inspire future healthcare professionals and advance vascular medicine innovation.